A meta-analysis conducted by Custodero et al. demonstrated that serum or plasma IL–6 and tumor necrosis factor (TNF)–α levels were significantly elevated in patients with VaD compared to healthy controls, but only IL–6 levels differed significantly between VaD and AD patients. The gene discussed is IL6; the disease is Alzheimer disease.